Literature DB >> 21178412

One step at a time: action mechanism of Sushi 1 antimicrobial peptide and derived molecules.

Sebastian Leptihn1, Lin Guo, Vladimir Frecer, Bow Ho, Jeak Ling Ding, Thorsten Wohland.   

Abstract

Antimicrobial peptides (AMPs) are a crucial part of the innate immune system of eukaryotes and present a possible alternative to common antibiotics. It is therefore of great importance to understand their modes of action. Using a single-molecule approach in combination with high resolution imaging and bio-functional assays we were able to determine the different steps occurring during the action of the α-helical AMP Sushi 1 during bacterial lysis in spatial and temporal resolution in a biologically relevant context. Furthermore, we comment on the use of Sushi 1 as a template for new peptides to learn more about structure-function relationship of AMPs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178412      PMCID: PMC3080192          DOI: 10.4161/viru.1.1.10229

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  14 in total

1.  High-affinity LPS binding domain(s) in recombinant factor C of a horseshoe crab neutralizes LPS-induced lethality.

Authors:  N S Tan; B Ho; J L Ding
Journal:  FASEB J       Date:  2000-05       Impact factor: 5.191

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

3.  Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides.

Authors:  N S Tan; M L Ng; Y H Yau; P K Chong; B Ho; J L Ding
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

4.  QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1.

Authors:  Vladimir Frecer
Journal:  Bioorg Med Chem       Date:  2006-05-22       Impact factor: 3.641

5.  High-performance affinity capture-removal of bacterial pyrogen from solutions.

Authors:  J L Ding; Y Zhu; B Ho
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-08-15

6.  Investigation of a novel artificial antimicrobial peptide by fluorescence correlation spectroscopy: an amphipathic cationic pattern is sufficient for selective binding to bacterial type membranes and antimicrobial activity.

Authors:  Lanlan Yu; Jeak Ling Ding; Bow Ho; Thorsten Wohland
Journal:  Biochim Biophys Acta       Date:  2005-10-01

7.  De novo design of potent antimicrobial peptides.

Authors:  V Frecer; B Ho; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 8.  Antibacterial peptides: basic facts and emerging concepts.

Authors:  H G Boman
Journal:  J Intern Med       Date:  2003-09       Impact factor: 8.989

Review 9.  The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin.

Authors:  Peng Li; Miao Sun; Thorsten Wohland; Bow Ho; Jeak Ling Ding
Journal:  Cell Mol Immunol       Date:  2006-02       Impact factor: 11.530

10.  Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria.

Authors:  Sebastian Leptihn; Jia Yi Har; Jianzhu Chen; Bow Ho; Thorsten Wohland; Jeak Ling Ding
Journal:  BMC Biol       Date:  2009-05-11       Impact factor: 7.431

View more
  3 in total

Review 1.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

Review 2.  Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19.

Authors:  Ritam Das; Komal Kotra; Pulkit Singh; Belinda Loh; Sebastian Leptihn; Urmi Bajpai
Journal:  Infect Dis Ther       Date:  2021-11-22

3.  The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability.

Authors:  Lingling Zhou; Kaiqi Lian; Mengting Wang; Xueyi Jing; Yuanchen Zhang; Jinling Cao
Journal:  BMC Microbiol       Date:  2022-09-19       Impact factor: 4.465

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.